Auth bypass in Smiths-Medical Cadd-Solis Medication Safety Software
CVE-2016-8355
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
Vulnerability class: Broken Authentication
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.9 (Critical). Vector: CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.015 (73.1th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 73rd percentile — 73.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.015 · newest: 0.015 · change: 0.000
Affected products
- Smiths-Medical Cadd-Solis Medication Safety Software — versions 1.0, 2.0, 3.0
- Smiths-Medical Cadd-Solis Medication Safety Software Through 3.1 — versions Smiths-Medical CADD-Solis Medication Safety Software through 3.1
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 (US Government Resource, Third Party Advisory)
- www.securityfocus.com/bid/94630 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2016-8355?
- CVE-2016-8355 is a critical-severity vulnerability in Smiths-Medical Cadd-Solis Medication Safety Software, classified under Missing Authentication for Critical Function. CVSS score: 9.9/10. Published 2017-02-13.
- How severe is CVE-2016-8355?
- Critical severity. CVSS v3 base score is 9.9 out of 10.